Published in Prostate on October 01, 1999
Chemotaxis in cancer. Nat Rev Cancer (2011) 3.68
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood (2004) 1.80
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem (2008) 1.71
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res (2010) 1.42
Breakdown of the endothelial barrier function in tumor cell transmigration. Biophys J (2007) 1.39
CXCL5 promotes prostate cancer progression. Neoplasia (2008) 1.37
The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal (2010) 1.27
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis (2008) 1.25
CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol (2001) 1.24
Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer. Am J Pathol (2005) 1.22
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway. Endocr Relat Cancer (2012) 1.14
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer. Pharmaceuticals (Basel) (2013) 1.10
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis. BMC Cancer (2004) 1.06
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia (2009) 1.03
Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci (2008) 1.02
Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam (2011) 1.01
CXC receptor-1 silencing inhibits androgen-independent prostate cancer. Cancer Res (2009) 1.00
Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res (2007) 0.98
Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer. PPAR Res (2012) 0.97
Role of the endothelium during tumor cell metastasis: is the endothelium a barrier or a promoter for cell invasion and metastasis? J Biophys (2009) 0.96
Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg (2010) 0.93
Neuroendocrine differentiation of prostate cancer. Asian J Androl (2013) 0.93
CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res (2015) 0.90
Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis. Br J Pharmacol (2014) 0.88
Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer. Mol Cancer Ther (2012) 0.87
CXCR2: a target for pancreatic cancer treatment? Expert Opin Ther Targets (2013) 0.87
Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer. Adv Healthc Mater (2012) 0.84
Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol (2005) 0.84
A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. Head Neck Oncol (2011) 0.83
Expression of CXCR2 and its clinical significance in human colorectal cancer. Int J Clin Exp Med (2015) 0.75
Binding of gastrointestinal tumor cells to endothelial E- and P-selectin adhesion receptors leads to transient down-regulation of sLeX ligands in vitro. Int J Colorectal Dis (2003) 0.75
Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
Neurite extension by peripheral and central nervous system neurons in response to substratum-bound fibronectin and laminin. Dev Biol (1983) 2.48
Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol (1995) 2.45
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J Cell Biol (1983) 2.07
Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J Cell Biol (1986) 1.98
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol (1984) 1.95
A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell (1993) 1.75
Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol (1999) 1.65
Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J Cell Biol (1988) 1.53
Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab Invest (1994) 1.52
Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin. J Biol Chem (1982) 1.52
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol (2001) 1.51
Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry (1988) 1.49
Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Cancer (1999) 1.49
RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities. J Cell Biol (1990) 1.44
Production of laminin and fibronectin by Schwannoma cells: cell-protein interactions in vitro and protein localization in peripheral nerve in vivo. J Cell Biol (1983) 1.44
Immunocytochemical localization of fibronectin (LETS proteins) on the surface of L6 myoblasts: light and electron microscopic studies. Cell (1978) 1.42
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell (1983) 1.42
Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest (1992) 1.36
Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest (1986) 1.36
The role of cell adhesion proteins--laminin and fibronectin--in the movement of malignant and metastatic cells. Cancer Metastasis Rev (1985) 1.36
Neuron-specific interactions with two neurite-promoting fragments of fibronectin. J Neurosci (1985) 1.34
Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med (1991) 1.30
Evidence for a satellite secretory pathway in neuronal dendritic spines. Curr Biol (2001) 1.30
A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol (1992) 1.29
A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin. J Cell Biol (1992) 1.27
Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect Immun (1995) 1.27
Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin. J Cell Biol (1992) 1.25
A novel synthetic peptide from the B1 chain of laminin with heparin-binding and cell adhesion-promoting activities. J Cell Biol (1988) 1.25
Guidance of neurite outgrowth by pathways of substratum-adsorbed laminin. J Neurosci Res (1985) 1.24
Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci U S A (1994) 1.23
Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem (2001) 1.23
The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem (1988) 1.21
Fibronectin presence in native collagen fibrils of human fibroblasts: immunoperoxidase and immunoferritin localization. J Histochem Cytochem (1980) 1.20
Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res (1995) 1.20
Transforming growth factor-beta 1 binds to immobilized fibronectin. J Cell Biochem (1989) 1.18
Localization of three distinct heparin-binding domains of laminin by monoclonal antibodies. J Biol Chem (1988) 1.17
CSPG4 in cancer: multiple roles. Curr Mol Med (2010) 1.15
CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest (1996) 1.15
Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol (1994) 1.14
Evidence that mitogenic lectins induce changes in lymphocyte membrane fluidity. Nature (1974) 1.14
Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest (1995) 1.13
Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin. J Cell Biol (1987) 1.13
Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev (1992) 1.12
Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest (1994) 1.12
Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies. J Biol Chem (1982) 1.12
A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function. JAMA (1980) 1.10
Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit. J Cell Biol (1991) 1.10
Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem (1982) 1.09
Fibronectin: review of its structure and possible functions. J Invest Dermatol (1981) 1.08
CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell (1996) 1.07
Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility. J Cell Biol (1990) 1.07
Cellular recognition of synthetic peptide amphiphiles in self-assembled monolayer films. Biomaterials (1999) 1.07
Dexamethasone-induced accumulation of a fibronectin and collagen extracellular matrix in transformed human cells. Nature (1979) 1.06
Stimulation of haptotaxis and migration of tumor cells by serum spreading factor. Cancer Res (1985) 1.06
Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res (2001) 1.06
Recognition of the A chain carboxy-terminal heparin binding region of fibronectin involves multiple sites: two contiguous sequences act independently to promote neural cell adhesion. J Cell Biol (1990) 1.06
Translocation machinery for synthesis of integral membrane and secretory proteins in dendritic spines. Nat Neurosci (2000) 1.06
A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J Biol Chem (1998) 1.06
Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab Invest (1989) 1.05
Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood (1996) 1.04
Ligand accessibility as means to control cell response to bioactive bilayer membranes. J Biomed Mater Res (2000) 1.04
Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes (1990) 1.04
Adhesion of lymphoid cells to the carboxyl-terminal heparin-binding domains of fibronectin. Exp Cell Res (1989) 1.02
Effect of vinblastine sulfate, colchicine and lumicolchicine on membrane organization of normal and transformed cells. Exp Cell Res (1975) 1.02
Construction of biologically active protein molecular architecture using self-assembling peptide-amphiphiles. Methods Enzymol (1997) 1.02
Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function. J Clin Invest (1998) 1.02
Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro. Invest Ophthalmol Vis Sci (1991) 1.01
The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin. J Biol Chem (1989) 1.01
Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple, distinct domains of the collagen molecule. Cancer Res (1989) 1.01
Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst (1992) 1.01